Table 2.
Liposomes | t1/2c (h) | VDd (mL) | AUCe0-24h (%ID/cc hr) |
CLf (mL/h) |
---|---|---|---|---|
In vivo | ||||
64Cu-DSPE liposomes (n = 4) | 18.46 | 3.41 | 646.9 | 0.102 |
64Cu-DPPE liposomes (n = 8) | 5.093 | 3.60 | 277.3 | 0.445 |
64Cu-DSPE-1mol% DPPC liposomes (n = 4) | 19.40 | 4.64 | 707.4 | 0.153 |
In vitro | ||||
64Cu-DPPE liposomes | 7.857g n/a | n/a | n/a |
pharmacokinetic parameters are derived from Figure 5a and b as described further in the supplement
the half clearance times were obtained from one phase exponential decay curve fit (Y = A e−k×t).
half clearance time
volume of distribution
area under curve at 24 hours
clearance from animal
half clearance was calculated based on Figure 5d (in vitro) by one-phase exponential decay curve fit (Y = A e−k×t).